Please login to the form below
Orexo hires new CEO as Biolipox acquisition closes
The board of directors of Swedish pharmaceutical company Orexo appoints Torbjoern Bjerke as new CEO of the company
The board of directors of Swedish pharmaceutical company Orexo has appointed Torbjoern Bjerke as new CEO of the company.
The appointment was announced at the same time as Orexo revealed it had finally acquired Biolipox.
Orexo has acquired all shares and warrants in Biolipox through payment consisting of 7,630,895 new shares in Orexo and 926,000 warrants allowing subscription for 926,000 new shares in Orexo.
Bjerke was previously CEO in Biolipox. As previously announced, Zsolt Lavotha, Orexo's former CEO, will leave his post and serve as Senior Advisor to Orexo's board.
The board of directors of Orexo has also prepared a prospectus regarding listing of shares in Orexo in connection with the acquisition of Biolipox.
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Senior External Communications Lead
-
£Competitive Salary
-
Account Manager (PR)
-
Great Benefits
-
Account Director
-
£Competitive Salary
-
Account Manager
-
£Competitive Salary
- New study identifies drugs that are safe to use in COVID-19 treatment
- China backs use of Roche’s Actemra for coronavirus
- Sanofi, Regeneron launch trials of arthritis drug Kevzara for COVID-19
- Novartis donates malaria drug for COVID-19 clinical trials
- AbbVie suspends Kaletra patent rights as COVID-19 drug trials advance
- MHRA raises concerns over fraudulent coronavirus tests
- Incyte and Novartis join coronavirus efforts with phase 3 study
- Moderna chairman says COVID-19 vaccine could begin phase 2 trials in spring
- Merck’s Keytruda beats chemo in first-line colorectal cancer
- “Fake News” and Credibility in Medical Publishing
- How Much Does Each Advisor “Insight” Actually Cost?
- It's not just our logo that's green
PMHub
Life Healthcare Communications
Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...
Latest intelligence
- “Fake News” and Credibility in Medical Publishing
- Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
- Delivering true value: what does it mean for KAM in cancer care?
- Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
- Pharma funding and M&A in 2020
- Why pharma M&A has continually bucked the trend...
Quick links
Infographics
